Evidence map›Paper›PMID 39436374›Full record

ArticleInvestigative ophthalmology & visual science2024

A New Retest-Stable Tortuosity Metric for Retinal Vessel Analyses.

Samuel David Giesser, Ferhat Turgut, Amr Saad, Chiara Sommer, Yukun Zhou, Siegfried Karl Wagner, Pearse Andrew Keane, Matthias Becker, Delia Cabrera DeBuc, Gábor Márk Somfai

Abstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Samuel David GiesserDepartment of Ophthalmology, Stadtspital Zürich, Zurich, Switzerland.
Ferhat TurgutDepartment of Ophthalmology, Stadtspital Zürich, Zurich, Switzerland.
Amr SaadDepartment of Ophthalmology, Stadtspital Zürich, Zurich, Switzerland.
Chiara SommerDepartment of Ophthalmology, Stadtspital Zürich, Zurich, Switzerland.
Yukun ZhouNIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
Siegfried Karl WagnerNIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
Pearse Andrew KeaneNIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
Matthias BeckerDepartment of Ophthalmology, Stadtspital Zürich, Zurich, Switzerland.
Delia Cabrera DeBucBascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, Florida, United States.
Gábor Márk SomfaiDepartment of Ophthalmology, Stadtspital Zürich, Zurich, Switzerland.

Funding

University of Utah, Core Vision Research GrantP30EY014800 · NEI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI PAUL STEVEN BERNSTEIN · 2005 to 2026
$14.6M
An AI-assisted screening platform within a multivariate framework for biomarkers of mild cognitive impairment due to Alzheimer's diseaseR41AG073066 · NIA · ISCREEN 2 PREVENT LLC · PI CABRERA-DEBUC, DELIA, MENDOZA-SANTIESTEBAN, CARLOS E. · 2021 to 2022
$521k
Medical Research CouncilNEI NIH HHS P30 EY014800NIA NIH HHS R41 AG073066
6 · The paper itself

Abstract

Purpose: Existing retinal vessel tortuosity metrics lack standardization and retest reliability, hindering their clinical utility. Our study addresses this gap by introducing a novel metric, coined as the "vascular curvature index" (VCI), to enhance accuracy and consistency in biomarkers associated with medical conditions. We assess VCI's performance in terms of retest reliability in healthy subjects to transform early detection and monitoring approaches for various diseases. Methods: We recruited 44 patients for a single-session study, capturing fundus images before and after a five-minute break. Using AutoMorph, we generated vessel segmentation maps and evaluated retest reliability using multiple tortuosity metrics. The VCI was introduced and statistically compared to existing metrics. We performed a paired one-sided t-test to test for significantly improved retest reliability of our newly proposed metric. We analyzed distribution histograms, Fisher-Pearson coefficient of skewness, and correlation matrices for further insights. Results: VCI is the most retest-reliable metric, statistically surpassing other curvature metrics, except inverse spherical radius tortuosity. With a somewhat negatively distributed pattern (coefficient of skewness of -0.52), VCI exhibits the strongest correlation with the second most retest-reliable metric; inverse-radius-tortuosity (Pearson and Spearman correlation of 0.7 and 0.72, respectively). Its correlation with angle-tortuosity is lower (Pearson and Spearman correlation of 0.05 and 0.07, respectively). Conclusions: The VCI emerges as a highly retest-reliable metric with a relatively normal distribution in healthy patients. Further investigation is warranted to evaluate its clinical performance in real-world applications, potentially influencing proactive healthcare interventions and personalized treatment decision-making.

Indexed as

Retinal VesselsAdultAgedFemaleFluorescein AngiographyHumansMaleMiddle AgedReproducibility of ResultsRetinal Diseases

Identifiers

PMID39436374
PMCPMC11500049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.